Stock News•1 week ago
Natera (NASDAQ:NTRA) Hits New 12-Month High – Here’s Why
Natera (NASDAQ:NTRA) hit a new 52-week high of $429.97 on Tuesday, up from a prior close of $425.64, as analysts issued recent upgrades and downgrades.
MarketLens
What's Driving Natera's Recent Stock Action
6 months ago
SHARE THIS ON:
Exclusive Content for Pro Members
Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.
SHARE THIS ON:
Related Articles
Category
You may also like
Stock News•1 months ago
Billionaire Stanley Druckenmiller Has Roughly 17% of His $5.2 Billion Duquesne Portfolio in Natera Stock. Is It Still a Buy After an 80% Run?
Natera, a genetic testing leader, has risen ~80% and represents roughly 17% of Stanley Druckenmiller's $5.2B Duquesne portfolio, reflecting strong conviction in the company's prospects.
Stock News•2 months ago
Natera to Support New Clinical Trial Assessing ctDNA Dynamics with Latitude™ in Advanced Skin Cancers
Natera's Latitude assay will support Kupando Therapeutics' Phase 1 trial of KUP-101 in advanced skin cancers, assessing serial ctDNA dynamics. The collaboration could expand Natera's MRD testing reach...
Breaking News
View All →No topics available at the moment
Featured Articles
Top Headlines
Stock News•54 minutes ago
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Alphabet Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOOGL, GOOG
Stock News•1 hour ago
Why the Market Dipped But Meta Platforms (META) Gained Today
Stock News•1 hour ago
Nvidia in 5 Years: Where the Stock Could Be Headed
Stock News•2 hours ago
UK finance minister Healey to target online marketplaces in tax crackdown, The Times reports
Stock News•2 hours ago